Home › Giant Cell Arteritis
Giant Cell Arteritis clinical trials recruiting in the U.S.
8 studies for Giant Cell Arteritis are recruiting participants at sites across the United States.
Giant cell arteritis causes inflammation and narrowing of the arteries in the head. It often occurs with the disease polymyalgia rheumatica. Learn more.
Cities with the most studies
By state
Recently updated studies
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Sep 25, 2026 · NCT05865054Abatacept for the Treatment of Giant Cell Arteritis
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Aug 20, 2026 · NCT04474847Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
RecruitingObservational studyHealthy volunteers welcome
Ages 3 and older · All sexes · Updated Aug 17, 2026 · NCT02257866Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 10, 2026 · NCT07108387Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898Rheumatology Patient Registry and Biorepository
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Feb 13, 2026 · NCT04402086One-Time DNA Study for Vasculitis
RecruitingObservational study
Ages 7 and older · All sexes · Updated Jan 22, 2026 · NCT01241305VCRC Tissue Repository
RecruitingObservational study
All ages · All sexes · Updated Jan 22, 2026 · NCT02967068From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.